Oppenheimer: Teva Pharmaceutical Industries Is Now Worth $77 Per Share, More Deals To Come


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Oppenheimer upgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) Tuesday from Perform to Outperform and set a price target of $77.

 

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Analysts Akiva Felt and Angad Verma expected more deals to come following the announcement that the company would acquire Auspex Pharmaceuticals Inc (NASDAQ: ASPX).

 

The analysts felt the company would "continue rebuilding through M&A, with the capacity for additional smaller deals to build pipeline value, along with a larger deal focused on generics and established branded products."

 

Felt and Verma throught that Mallinckrodt PLC (NYSE: MNK) would make sense for an acquisition, however, there were "multiple options for Teva" to pursue with numerous events in the pipeline.


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


 

 

The $77 price target was based on a DCF valuation discounted at 9 percent through 2020 and a terminal value (0 percent terminal growth) discounted at 10 percent.

 

The price target also represented a 14.9x multiple on the firm's 2016 EPS estimate of $5.03, "still modestly below other spec-pharma turnaround stories," according to the analysts.


Felt and Verma concluded, "While we wish we had been earlier with the upgrade, we think this turnaround story still has legs."

 

Teva Pharmaceutical Industries Ltd (ADR) recently traded at $62.67, up 0.24 percent.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: UpgradesPrice TargetAnalyst RatingsAkiva FeltAngad VermaOppenheimer